Conjunctival microangiopathy in type-II diabetes.

被引：0
|
作者：
Greer, DA
BanksJackson, R
Ramanujam, S
Chen, PCY
Cheung, ATW
机构：
[1] UNIV CALIF DAVIS,DAVIS,CA 95616
[2] UNIV CALIF SAN DIEGO,SAN DIEGO,CA 92093
来源：
FASEB JOURNAL | 1996年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1178 / 1178
页数：1
相关论文
共 50 条
  • [21] The benefits of glycemic control in type II diabetes.
    Vijan, S
    Hofer, TP
    Hayward, RA
    JOURNAL OF INVESTIGATIVE MEDICINE, 1996, 44 (07) : A362 - A362
  • [22] Microalbuminuria and angiotensin II in type 1 diabetes.
    Rasmusson, GE
    Zhao, L
    Sibley, SD
    JOURNAL OF INVESTIGATIVE MEDICINE, 2004, 52 (02) : S354 - S354
  • [23] Time course for development of functional skin microangiopathy in patients with Type 1 diabetes.
    Kalani, M
    Adamsson, U
    Lins, PE
    Östergren, J
    Jörneskog, G
    DIABETOLOGIA, 2003, 46 : A415 - A416
  • [24] Factors associated with mortality in type II diabetes.
    Leonetti, DL
    Shofer, J
    Boyko, E
    Fujimoto, WY
    DIABETES, 1996, 45 : 796 - 796
  • [25] TYPE-I AND TYPE-II DIABETES
    SCHERBAUM, WA
    MEDIZINISCHE WELT, 1991, 42 (11): : 911 - 913
  • [26] INTENSIVE MANAGEMENT OF TYPE-II DIABETES
    DUCKWORTH, WC
    POSTGRADUATE MEDICINE, 1991, 89 (04) : 65 - +
  • [27] PROGRESSION OF MICROALBUMINURIA IN TYPE-II DIABETES
    SMULDERS, YM
    RAKIC, M
    WEIJERS, RNM
    SLAATS, EH
    SILBERBUSCH, J
    DIABETOLOGIA, 1995, 38 : A63 - A63
  • [28] EXERCISE IN THE TREATMENT OF TYPE-II DIABETES
    KOIVISTO, VA
    DEFRONZO, RA
    ACTA ENDOCRINOLOGICA, 1984, 105 : 107 - 111
  • [29] PREDICTORS OF TYPE-II DIABETES IDENTIFIED
    RAUB, W
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (13): : 1633 - 1633
  • [30] PERSPECTIVES ON THE MANAGEMENT OF TYPE-II DIABETES
    SIMMONS, MW
    OWEN, N
    AUSTRALIAN PSYCHOLOGIST, 1992, 27 (02) : 99 - 102
12345